S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
NASDAQ:ISPC

iSpecimen (ISPC) Stock Price, News & Analysis

$0.21
0.00 (0.00%)
(As of 04/16/2024 ET)
Today's Range
$0.21
$0.23
50-Day Range
$0.21
$0.48
52-Week Range
$0.20
$2.05
Volume
71,834 shs
Average Volume
144,300 shs
Market Capitalization
$1.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ISPC stock logo

About iSpecimen Stock (NASDAQ:ISPC)

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

ISPC Stock Price History

ISPC Stock News Headlines

Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Nvidia GTC AI conference: What to watch
iSpecimen Full Year 2023 Earnings: Misses Expectations
iSpecimen Inc: iSpecimen Reports Full Year 2023 Results
iSpecimen Reports Full Year 2023 Results
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
iSpecimen: Q4 Earnings Insights
Fed rate cuts likely coming after June -strategist
iSpecimen Inc ISPC
See More Headlines
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2024
Today
4/16/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:ISPC
Fax
N/A
Employees
53
Year Founded
N/A

Profitability

Net Income
$-11,100,000.00
Net Margins
-111.81%
Pretax Margin
-111.79%

Debt

Sales & Book Value

Annual Sales
$9.93 million
Book Value
$1.07 per share

Miscellaneous

Free Float
6,309,000
Market Cap
$1.99 million
Optionable
Not Optionable
Beta
1.70
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Ms. Tracy Wilson Curley (Age 62)
    CEO, CFO, Treasurer & Director
    Comp: $437.5k
  • Mr. Benjamin Bielak (Age 54)
    Chief Information Officer & Secretary
    Comp: $391.2k
  • Ms. Carly Lejnieks
    Vice President of Marketing
  • Ms. Annette Arnold
    Vice President of Sales & Business Development
  • Mr. David Wages M.D.
    Ph.D., Chief Medical Officer
  • Mr. Eric Langlois
    Chief Revenue Officer
  • Mr. Evan Cox
    Senior Vice President of Strategy & Innovation

ISPC Stock Analysis - Frequently Asked Questions

How have ISPC shares performed in 2024?

iSpecimen's stock was trading at $0.5006 on January 1st, 2024. Since then, ISPC shares have decreased by 57.6% and is now trading at $0.2121.
View the best growth stocks for 2024 here
.

Are investors shorting iSpecimen?

iSpecimen saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 459,500 shares, an increase of 2,826.8% from the March 15th total of 15,700 shares. Based on an average daily trading volume, of 145,700 shares, the short-interest ratio is currently 3.2 days. Approximately 8.6% of the company's stock are short sold.
View iSpecimen's Short Interest
.

When is iSpecimen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ISPC earnings forecast
.

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) posted its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.34) EPS for the quarter. The company had revenue of $2.58 million for the quarter. iSpecimen had a negative trailing twelve-month return on equity of 80.37% and a negative net margin of 111.81%.

When did iSpecimen IPO?

iSpecimen (ISPC) raised $20 million in an initial public offering (IPO) on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ISPC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners